3004.20.00.55 - Containing clindamycin or its salts 🖩

This HTS category, 3004.20.00.55, specifically covers medicaments containing clindamycin or its salts. These are pharmaceutical products formulated for therapeutic or prophylactic purposes, presented in measured doses or in retail packaging. Clindamycin is a lincosamide antibiotic used to treat a variety of bacterial infections, including those affecting the skin, lungs, and reproductive organs. The classification is contingent upon the presence of clindamycin as a primary active ingredient in the medicament.

To differentiate this category from its siblings, it is important to note the specific antibiotic content. While 3004.20.00.45 is for azithromycin and 3004.20.00.65 is for doxycycline, this category is exclusively for products where clindamycin is the active antibiotic. The residual sibling category, 3004.20.00.75, serves as a catch-all for other antibiotics not otherwise specified.

As a leaf node, this classification does not have further subcategories. Therefore, the focus for classification remains on the accurate identification of clindamycin or its salts as the principal active component within the medicament, packaged and presented for direct therapeutic use. This ensures precise adherence to the specific pharmaceutical ingredient requirements outlined in the Harmonized Tariff Schedule.